Sugentech Inc. (253840.KQ)

KRW 5610.0

(1.63%)

EBITDA Summary of Sugentech Inc.

Sugentech Inc.'s latest annual EBITDA in 2023 was -12.13 Billion KRW , down -162.88% from previous year.
Sugentech Inc.'s latest quarterly EBITDA in 2024 Q2 was -4.05 Billion KRW , up 7.38% from previous quarter.
Sugentech Inc. reported an annual EBITDA of 38.07 Billion KRW in 2022, down -21.05% from previous year.
Sugentech Inc. reported an annual EBITDA of 46.34 Billion KRW in 2021, up 54.77% from previous year.
Sugentech Inc. reported a quarterly EBITDA of -3.89 Billion KRW for 2024 Q1, up 30.51% from previous quarter.
Sugentech Inc. reported a quarterly EBITDA of -4.67 Billion KRW for 2023 Q3, up 9.63% from previous quarter.

Annual EBITDA Chart of Sugentech Inc. (2023 - 2015)

Historical Annual EBITDA of Sugentech Inc. (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-12.13 Billion KRW	-162.88%
2022	38.07 Billion KRW	-21.05%
2021	46.34 Billion KRW	54.77%
2020	-39.35 Billion KRW	463.03%
2019	-8.5 Billion KRW	-57.58%
2018	-38.82 Billion KRW	-54.83%
2017	-18.82 Billion KRW	-85.55%
2016	-1.32 Billion KRW	-4.78%
2015	-1.3 Billion KRW	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-4.05 Billion KRW	7.38%
2024 Q1	-3.89 Billion KRW	30.51%
2023 Q3	-4.67 Billion KRW	9.63%
2023 Q1	-5.53 Billion KRW	77.24%
2023 FY	- KRW	-162.88%
2023 Q4	-2.58 Billion KRW	44.67%
2023 Q2	-5.17 Billion KRW	6.38%
2022 Q1	45.25 Billion KRW	279.02%
2022 FY	- KRW	-21.05%
2022 Q4	-24.3 Billion KRW	-930.74%
2022 Q3	-2.35 Billion KRW	-123.59%
2022 Q2	9.99 Billion KRW	-77.92%
2021 Q1	5.78 Billion KRW	59.03%
2021 Q2	-480.19 Million KRW	-108.31%
2021 Q3	18.96 Billion KRW	4050.14%
2021 FY	- KRW	54.77%
2021 Q4	11.93 Billion KRW	-37.06%
2020 Q4	3.63 Billion KRW	178.78%
2020 Q2	20.33 Billion KRW	1181.08%
2020 Q1	-1.88 Billion KRW	-10.43%
2020 FY	- KRW	463.03%
2020 Q3	1.3 Billion KRW	-93.59%
2019 Q3	-1.61 Billion KRW	20.01%
2019 FY	- KRW	-57.58%
2019 Q4	-1.7 Billion KRW	-5.77%
2019 Q2	-2.01 Billion KRW	-80.24%
2019 Q1	-1.11 Billion KRW	-11.14%
2018 Q3	-1.06 Billion KRW	0.0%
2018 Q4	-1 Billion KRW	5.35%
2018 FY	- KRW	-54.83%
2017 FY	- KRW	-85.55%
2016 FY	- KRW	-4.78%
2015 FY	- KRW	0.0%

Peer EBITDA Comparison of Sugentech Inc.

Name	EBITDA	EBITDA Difference
Osang Healthcare Co.,Ltd	157.89 Billion KRW	107.684%
InBody Co.,Ltd	44.25 Billion KRW	127.411%
Curexo Inc.	-2.75 Billion KRW	-340.559%
Seegene, Inc.	35.65 Billion KRW	134.024%
i-SENS, Inc.	24.14 Billion KRW	150.245%
Ray Co., Ltd.	7.62 Billion KRW	259.118%
Gencurix Inc.	-18.09 Billion KRW	32.949%
L&C Bio Co., Ltd	13.4 Billion KRW	190.518%